New therapeutic approaches to pleural infection

Current Opinion in Infectious Diseases

Volumn 26, Issue 2, 2013, Pages 196-202

  Corcoran, John P ^a,b   Hallifax, Robert ^a,b   Rahman, Najib M ^a,b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

DNase; Empyema; Fibrinolytics; Pleural infection; TPA

Indexed keywords

ANTIBIOTIC AGENT; FIBRINOLYTIC AGENT; LOCAL ANESTHETIC AGENT; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; DRUG PREFERENCE; FIBRINOLYTIC THERAPY; HUMAN; LOCAL ANESTHESIA; PLEURA DISEASE; PLEURAL INFECTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SURGICAL DRAINAGE; THORACOSCOPY; THORACOTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRAINAGE; FIBRINOLYTIC AGENTS; HUMANS; PLEURAL DISEASES;

EID: 84874940338     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32835d0b71     Document Type: Review

References (44)

1. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011; 66:663-668.
2. Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007; 133:346-351.
3. Byington CL, Hulten KG, Ampofo K, et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010; 48:520-525.
4. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010; 125:26-33.
5. Munoz-Almagro C, Jordan I, Gene A, et al. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46:174-182. (Pubitemid 351269154)
6. Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 2011; 53:254-261.
7. Koshy E, Murray J, Bottle A, et al. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax 2010; 65:770-774.
8. Maskell NA, Davies CW, Nunn AJ, et al., First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352:865-874. (Pubitemid 40300295)
9. Meyer CN, Rosenlund S, Nielsen J, Friis-Moller A. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis 2011; 43:165-169.
10. Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174:817-823. (Pubitemid 44511664)
11. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980; 69:507-512. (Pubitemid 10018705)
12. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and videoassisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006; 174:221-227. (Pubitemid 44015396)
13. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365:518-526.
14. Davies HE, Davies RJ, Davies CW, BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline. Thorax 2010; 65 (Suppl. 2):ii41-ii53.
15. Balfour-Lynn IM, Abrahamson E, Cohen G, et al., Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 2005; 60 (Suppl. 1): i1-i21.
16. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118:1158-1171.
17. Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest 1989; 95:945-947. (Pubitemid 19136976)
18. Lin YC, Chen HJ, Liu YH, et al. A 30-month experience of thoracic empyema in a tertiary hospital: emphasis on differing bacteriology and outcome between the medical intensive care unit (MICU) and medical ward. South Med J 2008; 101:484-489.
19. Langley JM, Kellner JD, Solomon N, et al. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 2008; 8:129.
20. Marks DJ, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS One 2012; 7:e30074.
21. Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011; 66:658-662.
22. Insa R, Marín M, Martín A, et al. Systematic use of universal 16S rRNA gene polymerase chain reaction and sequencing for processing pleural effusions improves conventional culture techniques. Medicine (Baltimore) 2012; 91:103-110.
23. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30:289-294.
24. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal deoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest 1949; 28:173-190.
25. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004; 2:CD002312.
26. Thomson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002; 57:343-347. (Pubitemid 34298933)
27. Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000; 178:13-18. (Pubitemid 30111713)
28. Thommi G, Shehan JC, Robison KL, et al. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med 2012; 106:716-723.
29. Rahman NM, Ali NJ, Brown G, et al., BTS Pleural Disease Guideline Group. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline. Thorax 2010; 65 (Suppl 2):ii54-ii60.
30. Silen ML, Naunheim KS. Thoracoscopic approach to the management of empyema thoracis. Indications and results. Chest Surg Clin North Am 1996; 6:491-499. (Pubitemid 26247282)
31. Brutsche MH, TassiGF, Györik S, et al. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest 2005; 128:3303-3309. (Pubitemid 41698655)
32. Ravaglia C, Gurioli C, Tomassetti S, et al. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic empyema? Respiration 2012; 84:219-224.
33. Suchar AM, Zureikat AH, Glynn L, et al. Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema? Am Surg 2006; 72:688-692. (Pubitemid 351837654)
34. Soliani L, Prusciano F, Bagioni P. Video-assisted thoracic surgery in the treatment of pleural empyema. Surg Endosc 2007; 21:280-284. (Pubitemid 46122418)
35. Pappalardo E, Laungani A, Demarche M, Erpicum P. Early thoracoscopy for the management of empyema in children. Acta Chir Belg 2009; 109:602-605.
36. Pluijms WA, Steegers MA, Verhagen AF, et al. Chronic postthoracotomy pain: a retrospective study. Acta Anaesthesiol Scand 2006; 50:804-808. (Pubitemid 44034230)
37. Mongardon N, Pinton-Gonnet C, Szekely B, et al. Assessment of chronic pain after thoracotomy: a 1-year prevalence study. Clin J Pain 2011; 27:677-681.
38. Kurt BA, Winterhalter KM, Connors RH, et al. Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage. Pediatrics 2006; 118:e547-e553. (Pubitemid 46089980)
39. St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 2009; 44:106-111.
40. Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 1997; 111:1548-1551. (Pubitemid 27260081)
41. Bilgin M, Akcali Y, Oguzcaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg 2006; 76:120-122. (Pubitemid 43363010)
42. Chambers A, Routledge T, Dunning J, Scarci M. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema? Interact Cardiovasc Thorac Surg 2010; 11:171-177.
43. Tacconi F, Pompeo E, Fabbi E, Mineo TC. Awake video-assisted pleural decortication for empyema thoracis. Eur J Cardiothorac Surg 2010; 37:594-601.
44. Kho P, Karunanantham J, Leung M, Lim E. Debridement alone without decortication can achieve lung re-expansion in patients with empyema: an observational study. Interact Cardiovasc Thorac Surg 2011; 12:724-727.